老虎證券

BRIEF-Adagio Medical To List On Nasdaq Through Business Combination With ARYA Sciences Acquisition Corp IV

Reuters
2024/02/14

Feb 14 (Reuters) - ARYA Sciences Acquisition Corp IV

:

* ADAGIO MEDICAL TO LIST ON NASDAQ THROUGH BUSINESS COMBINATION WITH ARYA SCIENCES ACQUISITION CORP IV, ENABLING FURTHER COMMERCIAL AND CLINICAL DEVELOPMENT OF INNOVATIVE CARDIAC ABLATION TECHNOLOGIES

* ARYA SCIENCES ACQUISITION CORP IV - TRANSACTION IMPLIES A POST-TRANSACTION FULLY DILUTED EQUITY VALUE OF COMBINED COMPANY OF $128 MILLION

* ARYA SCIENCES ACQUISITION CORP IV: COMBINED CO EXPECTS TO RECEIVE ABOUT $42 MILLION FROM EQUITY AND CONVERTIBLE NOTE INVESTORS AT CLOSING

* ARYA SCIENCES ACQUISITION CORP IV - TRANSACTION IMPLIES A POST-TRANSACTION FULLY DILUTED ENTERPRISE VALUE OF $113 MILLION OF COMBINED CO

* ARYA SCIENCES ACQUISITION CORP IV: INC." COMBINED CO'S COMMON STOCK EXPECTED TO BE LISTED ON NASDAQ UNDER TICKER SYMBOL "ADGM"

* ARYA SCIENCES ACQUISITION CORP IV - CURRENT INVESTORS IN ADAGIO MEDICAL ARE EXPECTED TO OWN ABOUT 10.2% OF COMBINED CO

* ARYA SCIENCES ACQUISITION CORP IV - PERCEPTIVE AND ARYA SCIENCES HOLDINGS IV COLLECTIVELY, ARE EXPECTED TO HOLD ABOUT 58.2% OF COMBINED CO

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10